Literature DB >> 2714362

Response by the neurotensin systems of the basal ganglia to cocaine treatment.

G R Hanson1, P Smiley, M Johnson, A Letter, L Bush, J W Gibb.   

Abstract

Multiple administrations of high doses of cocaine had profound effects on the neurotensin (NT) systems of the basal ganglia. Approximately 200-300% increases in striatal content of neurotensin-like immunoreactivity (NTLI) were observed 1-8 h following five doses of 30 mg/kg per dose of cocaine. The effect subsided by 48 h after treatment. Significant changes in striatal NTLI levels were not observed after a single dose of this stimulant. The nigral NT systems appeared to be even more sensitive to cocaine administration. Compared to striatal changes, increases in nigral NTLI content were greater (as much as 455% of control), required lower cocaine doses (20 mg/kg per dose), lasted longer (still elevated to 200% of control after 48 h) and were significant following a single cocaine exposure. The response of the striatal NT systems to cocaine appeared to be mediated principally by dopamine D-1 receptors, while both D-1 and D-2 receptors contributed to the response by the nigral NT projections. Specific dopamine, but not serotonin, uptake blockers caused increases in striatal and nigral NTLI concentrations similar to that seen with cocaine treatments, suggesting that interference with the dopamine uptake carrier complex by cocaine was responsible for its actions on extrapyramidal NT systems.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2714362     DOI: 10.1016/0014-2999(89)90650-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

Review 1.  The role of neurotensin in central nervous system pathophysiology: what is the evidence?

Authors:  Fannie St-Gelais; Claudia Jomphe; Louis-Eric Trudeau
Journal:  J Psychiatry Neurosci       Date:  2006-07       Impact factor: 6.186

2.  Striatal and ventral pallidum dynorphin concentrations are markedly increased in human chronic cocaine users.

Authors:  Paul S Frankel; Mario E Alburges; Lloyd Bush; Glen R Hanson; Stephen J Kish
Journal:  Neuropharmacology       Date:  2008-04-29       Impact factor: 5.250

3.  Effects of neurotensin gene knockout in mice on the behavioral effects of cocaine.

Authors:  F Scott Hall; Marjorie Centeno; Maria T G Perona; Jordan Adair; Paul R Dobner; George R Uhl
Journal:  Psychopharmacology (Berl)       Date:  2011-07-01       Impact factor: 4.530

4.  Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801.

Authors:  J Stewart; J P Druhan
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Effect of low doses of methamphetamine on rat limbic-related neurotensin systems.

Authors:  Mario E Alburges; Amanda J Hoonakker; Nathaniel M Cordova; Christina M Robson; Lisa M McFadden; Amber L Martin; Glen R Hanson
Journal:  Synapse       Date:  2015-06-11       Impact factor: 2.562

6.  Neurotensin gene expression and behavioral responses following administration of psychostimulants and antipsychotic drugs in dopamine D(3) receptor deficient mice.

Authors:  C Betancur; I Lépée-Lorgeoux; M Cazillis; D Accili; S Fuchs; W Rostène
Journal:  Neuropsychopharmacology       Date:  2001-02       Impact factor: 7.853

7.  Responses of the rat basal ganglia neurotensin systems to low doses of methamphetamine.

Authors:  Mario E Alburges; Amanda J Hoonakker; Nathaniel M Cordova; Christina M Robson; Lisa M McFadden; Amber L Martin; Glen R Hanson
Journal:  Psychopharmacology (Berl)       Date:  2014-02-13       Impact factor: 4.530

8.  Response of neurotensin basal ganglia systems during extinction of methamphetamine self-administration in rat.

Authors:  Glen R Hanson; Amanda J Hoonakker; Christina M Robson; Lisa M McFadden; Paul S Frankel; Mario E Alburges
Journal:  J Pharmacol Exp Ther       Date:  2013-05-17       Impact factor: 4.030

9.  Nicotinic and dopamine D2 receptors mediate nicotine-induced changes in ventral tegmental area neurotensin system.

Authors:  Mario E Alburges; Amanda J Hoonakker; Glen R Hanson
Journal:  Eur J Pharmacol       Date:  2007-07-24       Impact factor: 4.432

10.  Altered neurotensin mrna expression in mice lacking the dopamine transporter.

Authors:  C Roubert; C Spielewoy; P Soubrié; M Hamon; B Giros; C Betancur
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.